Medicine and Dentistry
Patient
100%
Malignant Neoplasm
43%
Association
37%
Therapeutic Procedure
36%
Age
31%
Analysis
29%
Neoplasm
28%
Hispanic
27%
Human Immunodeficiency Virus
23%
Diagnosis
22%
Child
22%
Combination Therapy
21%
Gene
18%
COVID-19
17%
Breast Cancer
16%
Woman
16%
Diseases
15%
Health
15%
Dementia
15%
Cells
15%
Inpatient
15%
Odds Ratio
15%
Mortality
15%
Prostate Cancer
13%
Survival
13%
Man
13%
Development
13%
Heart
13%
Clinical Trial
12%
Male
12%
Alzheimer's Disease
12%
Female
11%
Biological Marker
11%
Tissues
11%
Adult
11%
Rhabdomyosarcoma
11%
Injury
11%
Young Adult
11%
Health Care Cost
10%
Obesity
10%
Aging
10%
Surgery
10%
Drug
10%
Cohort Analysis
10%
Prevalence
10%
Screening
10%
Antiretroviral Therapy
10%
Electronic Health Record
9%
Evaluation Study
9%
Prostate Specific Antigen
9%
Assessment
9%
Learning
9%
Chemotherapeutic Agent
9%
Incidence
8%
Infection
8%
Exercise
8%
Ganglioglioma
8%
Pediatrics
8%
Glioblastoma
7%
Growth
7%
Complication
7%
Marker
7%
Athletic Training
7%
Symptom
7%
Brain
7%
Tau
7%
Plasma
7%
Physician
7%
Childhood Cancer
7%
Life
7%
Xenograft
7%
Predictor
7%
Acute Lymphoblastic Leukemia
7%
Follow up
6%
Measurement
6%
Comprehension
6%
Cognition
6%
Depression
6%
Clinical Research
6%
Macrophage
6%
Primary Health Care
6%
Cerebrovascular Disease
6%
Mutant
6%
Disparity
5%
Race
5%
Older Adult
5%
Hospital
5%
Metastatic Carcinoma
5%
Systematic Review
5%
Gene Expression
5%
Blood
5%
Blood Pressure
5%
Lifespan
5%
Serositis
5%
Veteran
5%
Magnetic Resonance Imaging
5%
Phenotype
5%
Randomized Controlled Trial
5%
Hazard Ratio
5%
Pathology
5%
Biochemistry, Genetics and Molecular Biology
Nested Gene
49%
Association
25%
Sample
19%
Age
17%
Survival
15%
Protein
13%
Aging
11%
Mouse
11%
MicroRNA
10%
Development
10%
Gene Expression
10%
Electric Potential
10%
Regulatory Mechanism
10%
Mutation
10%
Growth
10%
Time
9%
Health
9%
Childhood
9%
RNA Sequence
9%
Pediatrics
8%
Methylation
8%
Transcription Factor
8%
Genetics
8%
DNA Methylation
8%
Comprehension
7%
RNA
7%
Sequencing
7%
Cancer Cell
6%
Messenger RNA
6%
Gene Dosage
5%
Cognition
5%
Microarray
5%
Genetic Divergence
5%
Phenotype
5%
DNA
5%
Genotyping
5%
Introspection
5%
Volume
5%
Life
5%
Mutant
5%
Nursing and Health Professions
Patient
34%
Malignant Neoplasm
17%
Time
15%
Procedures
15%
Hispanic
15%
Child
11%
Antiretroviral Therapy
10%
Hospital
9%
Diagnosis
9%
Analysis
8%
Prevalence
8%
Combination Therapy
7%
Breast Cancer
7%
Confidence Interval
7%
Odds Ratio
7%
Woman
7%
Control
6%
Prevention
6%
Mortality
6%
Veteran
6%
Standard
6%
Adult
5%
Quality of Life
5%
Electric Potential
5%
Body Mass
5%
Sample
5%
Incidence
5%
Inpatient
5%
Diabetes Mellitus
5%
Screening
5%